NEUROCRINE BIOSCIENCES INC
NBIX
71 insider filings · Latest: Sep 11, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Feb 10, 2025 | Feb 10 9:31 PM | EIRY WYN ROBERTS | Proposed Sale | 980 | $122.62 | $120.2K | — | View → |
| Feb 10, 2025 | Feb 10 9:30 PM | MATTHEW C ABERNETHY | Proposed Sale | 980 | $122.62 | $120.2K | — | View → |
| Feb 3, 2025 | Feb 3 9:19 PM | INGRID DELAET | Proposed Sale | 623 | $151.82 | $94.6K | — | View → |
| Jan 31, 2025 | Jan 31 9:34 PM | JULIE COOKE | Proposed Sale | 824 | $153.29 | $126.3K | — | View → |
| Jan 31, 2025 | Jan 31 9:33 PM | KEVIN CHARLES GORMAN | Proposed Sale | 2,707 | $153.29 | $415.0K | — | View → |
| Jan 31, 2025 | Jan 31 9:32 PM | EIRY WYN ROBERTS | Proposed Sale | 1,457 | $153.29 | $223.3K | — | View → |
| Jan 31, 2025 | Jan 31 9:32 PM | INGRID DELAET | Proposed Sale | 422 | $153.29 | $64.7K | — | View → |
| Jan 31, 2025 | Jan 31 9:31 PM | KYLE GANO | Proposed Sale | 1,541 | $153.29 | $236.2K | — | View → |
| Jan 31, 2025 | Jan 31 9:29 PM | MATTHEW C ABERNETHY | Proposed Sale | 1,283 | $153.29 | $196.7K | — | View → |
| Jan 31, 2025 | Jan 31 9:29 PM | ERIC BENEVICH | Proposed Sale | 1,207 | $153.29 | $185.0K | — | View → |
| Jan 31, 2025 | Jan 31 9:28 PM | DAVID WARREN BOYER | Proposed Sale | 1,104 | $153.29 | $169.2K | — | View → |
| Jan 31, 2025 | Jan 31 9:28 PM | DARIN LIPPOLDT | Proposed Sale | 1,250 | $153.29 | $191.6K | — | View → |
| Jan 31, 2025 | Jan 31 9:28 PM | JULIE COOKE | Proposed Sale | 916 | $153.29 | $140.4K | — | View → |
| Jan 31, 2025 | Jan 31 9:27 PM | JUDE ONYIA | Proposed Sale | 126 | $153.29 | $19.3K | — | View → |
| Jan 27, 2025 | Jan 27 9:27 PM | KEVIN CHARLES GORMAN | Proposed Sale | 146,105 | $148.73 | $21.7M | — | View → |
| Jan 15, 2025 | Jan 15 9:19 PM | KYLE W GANO | Proposed Sale | 65,000 | $139.51 | $9.1M | — | View → |
| Dec 31, 2024 | Dec 31 9:17 PM | INGRID DELAET | Proposed Sale | 272 | $137.06 | $37.3K | — | View → |
| Dec 17, 2024 | Dec 17 9:29 PM | INGRID DELAET | Proposed Sale | 1,091 | $133.05 | $145.2K | — | View → |
| Nov 29, 2024 | Nov 29 6:41 PM | JUDE ONYIA | Proposed Sale | 2,331 | $126.59 | $295.1K | — | View → |
| Sep 13, 2024 | Sep 13 8:23 PM | DAVID WARREN BOYER | Proposed Sale | 4,756 | $121.28 | $576.8K | — | View → |
← Previous
Page 5 of 5
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Feb 13, 2026 | Feb 17 10:48 PM | David W. BoyerChief Corp. Affairs Officer | Grant/Award | 36,713 | $124.12 | 5,479(D) | View → |
| Feb 12, 2026 | Feb 17 10:48 PM | David W. BoyerChief Corp. Affairs Officer | Option Exercise | 1,600 | — | 4,801(D) | View → |
| Feb 13, 2026 | Feb 17 10:48 PM | Kyle GanoDirector, Chief Executive Officer | Grant/Award | 134,972 | $124.12 | 20,142(D) | View → |
| Feb 13, 2026 | Feb 17 10:48 PM | Kyle GanoDirector, Chief Executive Officer | Option Exercise | 4,807 | — | 2,566(D) | View → |
| Feb 12, 2026 | Feb 17 10:48 PM | Kyle GanoDirector, Chief Executive Officer | Option Exercise | 4,907 | — | 14,721(D) | View → |
| Feb 13, 2026 | Feb 17 10:47 PM | Jude OnyiaChief Scientific Officer | Option Exercise | 5,407 | — | 2,717(D) | View → |
| Feb 13, 2026 | Feb 17 10:47 PM | Jude OnyiaChief Scientific Officer | Grant/Award | 64,788 | $124.12 | 9,669(D) | View → |
| Feb 12, 2026 | Feb 17 10:47 PM | Jude OnyiaChief Scientific Officer | Option Exercise | 2,560 | — | 7,681(D) | View → |
| Feb 13, 2026 | Feb 17 10:46 PM | Eric BenevichChief Commercial Officer | Option Exercise | 4,044 | — | 2,083(D) | View → |
| Feb 13, 2026 | Feb 17 10:46 PM | Eric BenevichChief Commercial Officer | Grant/Award | 42,652 | $124.12 | 6,365(D) | View → |
| Feb 12, 2026 | Feb 17 10:46 PM | Eric BenevichChief Commercial Officer | Option Exercise | 2,005 | — | 6,017(D) | View → |
| Feb 13, 2026 | Feb 17 10:46 PM | Julie CookeChief Human Resources Officer | Option Exercise | 2,911 | — | 1,510(D) | View → |
| Feb 13, 2026 | Feb 17 10:46 PM | Julie CookeChief Human Resources Officer | Grant/Award | 31,854 | $124.12 | 4,754(D) | View → |
| Feb 12, 2026 | Feb 17 10:46 PM | Julie CookeChief Human Resources Officer | Option Exercise | 1,387 | — | 4,161(D) | View → |
| Feb 13, 2026 | Feb 17 10:45 PM | Darin LippoldtChief Legal Officer | Option Exercise | 4,100 | — | 2,083(D) | View → |
| Feb 13, 2026 | Feb 17 10:45 PM | Darin LippoldtChief Legal Officer | Grant/Award | 41,033 | $124.12 | 6,124(D) | View → |
| Feb 12, 2026 | Feb 17 10:45 PM | Darin LippoldtChief Legal Officer | Option Exercise | 1,792 | — | 5,377(D) | View → |
| Feb 13, 2026 | Feb 17 10:45 PM | Ingrid DelaetChief Regulatory Officer | Option Exercise | 2,760 | — | 1,359(D) | View → |
| Feb 13, 2026 | Feb 17 10:45 PM | Ingrid DelaetChief Regulatory Officer | Grant/Award | 36,713 | $124.12 | 5,479(D) | View → |
| Feb 12, 2026 | Feb 17 10:45 PM | Ingrid DelaetChief Regulatory Officer | Option Exercise | 1,600 | — | 4,801(D) | View → |